Liquidia (LQDA) Non-Current Debt (2019 - 2022)
Liquidia (LQDA) recorded quarterly Non-Current Debt of $19.9 million in Q4 2022, up 0.7% quarter-over-quarter from $19.7 million in Q3 2022, and up 90.96% on a YoY basis from $10.4 million in Q4 2021.
Liquidia (LQDA) Non-Current Debt (2019 - 2022) Analysis & Trends
Liquidia's Non-Current Debt history runs 4 years deep, the most recent figure standing at $19.9 million for Q4 2022.
- In Q4 2022, Non-Current Debt rose 90.96% year-over-year to $19.9 million; the TTM figure through Dec 2022 stood at $19.9 million (up 90.96% YoY), while the FY2022 annual figure was $19.9 million, up 90.96% from the prior year.
- Non-Current Debt was $19.9 million for Q4 2022 at Liquidia, up from $19.7 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $19.9 million in Q4 2022 to a low of $10.2 million in Q1 2021.
- Historically, Non-Current Debt has averaged $14.0 million across 4 years, with a median of $10.4 million in 2021.
- The sharpest annual moves came in 2020 and 2022: Non-Current Debt increased 0.0% in 2020, then surged 91.38% in 2022.
- A 4-year view of Non-Current Debt shows it stood at $10.3 million in 2019, then increased by 0.0% to $10.3 million in 2020, then gained by 1.14% to $10.4 million in 2021, then soared by 90.96% to $19.9 million in 2022.
- The last three Non-Current Debt figures came in at $19.9 million (Q4 2022), $19.7 million (Q3 2022), and $19.6 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 19.88 Mn |
| Dec 31, 2022 | 19.88 Mn |
| Sep 30, 2022 | 19.74 Mn |
| Sep 30, 2022 | 19.74 Mn |
| Jun 30, 2022 | 19.61 Mn |
| Jun 30, 2022 | 19.61 Mn |
| Mar 31, 2022 | 19.48 Mn |
| Mar 31, 2022 | 19.48 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 10.33 Mn |
| Sep 30, 2021 | 10.33 Mn |
| Jun 30, 2021 | 10.25 Mn |
| Jun 30, 2021 | 10.25 Mn |
| Mar 31, 2021 | 10.18 Mn |
| Mar 31, 2021 | 10.18 Mn |
| Dec 31, 2020 | 10.29 Mn |
| Dec 31, 2020 | 10.29 Mn |
| Dec 31, 2019 | 10.29 Mn |
| Dec 31, 2019 | 10.29 Mn |